Primary Objective:

To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd PHDESILSTYFL.

Inclusion criteria:

• Phototype Skin I,II, III e IV Integral skin test in the region
• Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

Exclusion criteria:

• Lactation or pregnancy
• Use of Antiinflammatory 30 days and/or immunossupression drugs for until 3 months before volunteers selection
• Disease which can cause immunosuppresion, such as diabetes, HIV
• Use of Antihistamines 30 days before selection
• Personnel history of atopy
• History of sensitivity or irritation for topic products
• Cutaneous active disease (local and/or general) which can modify the study results
• Use of new drugs and/or cosmetics during the study
• Cutaneous reactive
• Previous participation in studies using the same product in test
• Volunteer which has immunodeficiency congenital or acquired
• Relevant history or confirmation of alcohol or other drugs abuse
• Intolerance detected or suspected for some component of the sample tested
• Medecin or sponsor employees or their close family

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.